Human Laboratory Study of ASP8062 for Alcohol Use Disorder
The primary objective of this study is to evaluate the effects of ASP8062, 25 mg once a day and matched placebo, on alcohol cue-elicited alcohol craving during a human laboratory paradigm after 2 weeks of daily dosing among subjects with moderate to severe alcohol use disorder (AUD).
This Study is
No Longer Enrolling
For more information, please email the research team at alcoholstudy@ucdenver. edu or use the link to fill out the study contact information form: https://redcap.link/TrAIL_Lab For participating in the research study, you will be paid up to a total of $595.00. Payments will be pro-rated if you don't complete all parts of the study.
MoreAdult
- At least 21 years of age - Currently drinking alcohol on a regular basis - Meet criteria for Alcohol Use Disorder (AUD) of at least moderate severity - Desire to quit or cut down on your drinking - Willing to take the study medication (or matched placebo) for 6 weeks
Not everyone will qualify to be in the study. Other inclusion and exclusion criteria will be evaluated by the study team.
Treatment
National
Department Specific Free Standing Clinic
Outpatient CTRC
University of Colorado Hospital
Protocol Number: 21-4460
More information available at ClinicalTrials.gov: NCT05096117
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers